© 2003 European Society of Cardiology
Difficulties of introducing the National Service Framework for heart failure into general practice in the UK
a Newthorpe Medical Practice Chewton Street, Eastwood, Nottingham NG16 3HB, UK
b Department of Cardiovascular Medicine, Queen's Medical Centre Nottingham NG7 2UH, UK
* Corresponding author. Tel.: +44-1773-760202. E-mail address: nigelsparrow{at}aol.com
 |
Abstract |
|---|
Background: The National Service Framework (NSF) sets standards for the management of heart failure in the UK. Loop diuretics are commonly first prescribed in primary care. Some patients taking these drugs have heart failure and may benefit from other treatments including ACE inhibitors. Accurate diagnosis in primary care is essential for the aims of the NSF to be realised.
Aims: To investigate loop diuretic prescribing in general practice, to analyse recorded clinical features, patient investigations and ACE inhibitor use in this population.
Method: One thousand three hundred and one patients taking loop diuretics were identified from prescription records of seven general practices. Demographic details, clinical features, investigations and drug treatments were extracted from patient records.
Results: The prevalence of loop diuretic prescribing increased with age. Twenty percent of patients were attributed a diagnosis of heart failure but relevant clinical features were recorded in less than 50% of patient records. Open access echocardiography was used in 8.9% of patients. ACE inhibitors were prescribed in 39.8% of patients considered to have heart failure. 18.2% of these were taking the recommended target dose.
Conclusion: Loop diuretics are prescribed commonly, particularly in the elderly. There is no clear pattern of documented clinical features that leads to prescription of these drugs. Open access echocardiography is rarely used to aid diagnosis. ACE inhibitors are under-prescribed and under-dosed in patients diagnosed with heart failure in this study population.
Key Words: Loop diuretics • Heart failure • General practice • ACE inhibitors
Received August 5, 2002; Revised January 8, 2003; Accepted January 21, 2003
For relevant further reading, please refer to Ref. [17].
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. D Gillespie The diagnosis and management of chronic heart failure in the older patient Br. Med. Bull., February 22, 2006; 75-76(1): 49 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Adlam, P. Silcocks, and N. Sparrow Using BNP to develop a risk score for heart failure in primary care Eur. Heart J., June 1, 2005; 26(11): 1086 - 1093. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Valle, N. Aspromonte, S. Barro, C. Canali, E. Carbonieri, V. Ceci, M. Chinellato, G. Gallo, P. Giovinazzo, R. Ricci, et al. The NT-proBNP assay identifies very elderly nursing home residents suffering from pre-clinical heart failure Eur J Heart Fail, June 1, 2005; 7(4): 542 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S J Leslie, S P McKee, E A Imray, and M A Denvir Management of chronic heart failure: perceived needs of general practitioners in light of the new general medical services contract Postgrad. Med. J., May 1, 2005; 81(955): 321 - 326. [Abstract] [Full Text] [PDF]
|
|